Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 6, 2014, Pages 1021-1028

  Song, Yeong Hun ^a   Kim, Dae Wook ^a   Curtis Long, Marcus John ^b   Yuk, Heung Joo ^a   Wang, Yan ^a   Zhuang, Ningning ^a   Lee, Kon Ho ^a   Jeon, Kwon Seok ^c   Park, Ki Hun ^a  

^a Gyeongsang National University   (South Korea)

^b BRANDEIS UNIVERSITY   (United States)

^c Korea Forest Research Institute   (South Korea)

Author keywords

Carbinolamide; Cinnamic amide; Papain like protease; Tribulus terrestris

Indexed keywords

ANTIVIRUS AGENT; CINNAMIC AMIDE DERIVATIVE; FERULIC ACID; N CAFFEOYLTYRAMINE; N COUMAROYLTYRAMIN; N FERULOYLOCTOPAMINE; N FERULOYLTYRAMINE; PAPAIN LIKE PROTEASE; PROTEINASE; TERRESTRIAMIDE; TERRESTRIMINE; TRIBULUS TERRESTRIS EXTRACT; UNCLASSIFIED DRUG; 3C-LIKE PROTEASE, SARS CORONAVIRUS; AMIDE; CINNAMIC ACID DERIVATIVE; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; PLANT EXTRACT; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG ISOLATION; DRUG POTENCY; DRUG PURIFICATION; DRUG SENSITIVITY; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME INHIBITION; FRUIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; NONHUMAN; PROTEIN DEGRADATION; SARS CORONAVIRUS; STRUCTURE ANALYSIS; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; HUMAN; IC50; ISOLATION AND PURIFICATION; KINETICS; SEVERE ACUTE RESPIRATORY SYNDROME; STRUCTURE ACTIVITY RELATION; TRIBULUS; VIROLOGY;

AMIDES; CINNAMATES; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FRUIT; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; MOLECULAR STRUCTURE; PLANT EXTRACTS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STRUCTURE-ACTIVITY RELATIONSHIP; TRIBULUS; VIRAL PROTEINS;

EID: 84901856638     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00026     Document Type: Article

References (23)

1. Turk B. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov., 5, 785-799 (2006).
2. Baker SC. Coronaviruses: Molecular Biology. Encyclopedia of Virology 3rd ed., 1, 554-562 (2008).
3. Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, Wong SS, Leung SY, Chan KH, Yuen KY. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U.S.A., 102, 14040-14045 (2005).
4. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H, Zhang J, McEachern J, Field H, Daszak P, Eaton BT, Zhang S, Wang LF. Bats are natural reservoirs of SARS-like coronaviruses. Science, 310, 676-679 (2005).
5. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JM, Yang GS, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth TF, Bowness D, Czub M, Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani A, Li Y, Normand S, Stroher U, Tipples GA, Tyler S, Vogrig R, Ward D, Watson B, Brunham RC, Krajden M, Petric M, Skowronski DM, Upton C, Roper RL. The genome sequence of the SARS-associated coronavirus. Science, 300, 1399-1404 (2003).
6. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 300, 1394-1399 (2003).
7. Harcourt BH, Jukneliene D, Kanjanahaluethai A, Bechill J, Severson KM, Smith CM, Rota PA, Baker SC. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J. Virol., 78, 13600-13612 (2004).
8. Devaraj SG, Wang N, Chen Z, Chen Z, Tseng M, Barretto N, Lin R, Peters CJ, Tseng CT, Baker SC, Li K. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem., 282, 32208-32221 (2007).
9. Ratia K, Saikatendu KS, Santarsiero BD, Barretto N, Baker SC, Stevens RC, Mesecar AD. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc. Natl. Acad. Sci. U.S.A., 103, 5717-5722 (2006).
10. Ratia K, Pegan S, Takayama J, Sleeman K, Coughlin M, Baliji S, Chaudhuri R, Fu W, Prabhakar BS, Johnson ME, Baker SC, Ghosh AK, Mesecar AD. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc. Natl. Acad. Sci. U.S.A., 105, 16119-16124 (2008).
11. Ghosh AK, Takayama J, Rao KV, Ratia K, Chaudhuri R, Mulhearn DC, Lee H, Nichols DB, Baliji S, Baker SC, Johnson ME, Mesecar AD. Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation. J. Med. Chem., 53, 4968-4979 (2010).
12. Colland F. The therapeutic potential of deubiquitinating enzyme inhibitors. Biochem. Soc. Trans., 38, 137-143 (2010).
13. Bourke CA, Stevens GR, Carrigan MJ. Locomotor effects in sheep of alkaloids identified in Australian Tribulus terrestris. Aust. Vet. J., 69, 163-165 (1992).
14. Ren YJ, Chen HS, Yang GJ, Zhu H. Isolation and identification of a new derivative of cinnamic amide from Tribulus terrestris. Acta Pharm. Sin., 29, 204-206 (1994).
15. Li JX, Shi Q, Xiong QB, Prasain JK, Tezuka Y, Hareyama T, Wang ZT, Tanaka K, Namba T, Kadota S. Tribulusamide A and B, new hepatoprotective lignanamides from fruits of Tribulus terrestris: indications of cytoprotective activity in murine hepatocyte culture. Planta Med., 64, 628-631 (1998).
16. Saleh NAM, Ahmed AA, Abdalla MF. Flavonoid glycosides of Tribulus pentandrus and T. terrestris. Phytochemistry, 21, 1995-2000 (1982).
17. Kostova I, Dinchev D. Saponins in Tribulus terrestris - Chemistry and Bioactivity. Phytochem. Rev., 4, 111-137 (2005).
18. Akram M, Asif HM, Akhtar N, Shah PA, Uzair M, Shaheen G, Shamim T, Ali Shah SM, Ahmad K. Tribulus terrestris LINN.: A review article. J. Med. Plants Res., 5, 3601-3605 (2011).
19. Sun B, Qu WJ, Zhang XL, Yang HJ, Zhuang XY, Zhang P. Investigation on inhibitory and apoptosis-inducing effects of saponins from Tribulus terrestris on hepatoma cell line BEL-7402. Zhongguo Zhong Yao Za Zhi, 29, 681-684 (2004).
20. Jiji MJ, Visalakshi S, Meenakshi P, Rathi MA, Thirumoorthi LD, Chinna Guravaiah D, Gopalakrishnan VK. Antilipidemic activity of Cissus quadrangularis and Tribulus terrestris on obesity in high fat fed rats. Pharmacology online, 2, 1250-1258 (2009).
21. Kim DW, Seo KH, Curtis-Long MJ, Oh KY, Oh JW, Cho JK, Lee KH, Park KH. Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J. Enzyme Inhib. Med. Chem., 29, 59-63 (2014).
22. Bradford MM. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
23. Lee DG, Park Y, Kim MR, Jung HJ, Seu YB, Hahm KS, Woo ER. Anti-fungal effects of phenolic amides isolated from the root bark of Lycium chinense. Biotechnol. Lett., 26, 1125-1130 (2004).